Tumor necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study of patients treated with BFM therapy

Podobne knjige/članki

• Genetic polymorphisms of the lymphotoxin alpha gene are associated with increased risk for lethal infections during induction therapy for childhood acute leukemia: a case-control study
  od: Kidas, Ekaterini, et al.
  Izdano: (2009)
• Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia
  od: Lauten, Melchior, et al.
  Izdano: (2012)
• NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia
  od: Bandapalli, Obul R., et al.
  Izdano: (2013)
• Bridging the gap between the north and south of the world: the case of treatment response in childhood acute lymphoblastic leukemia
  od: Stanulla, Martin, et al.
  Izdano: (2009)
• High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol
  od: Cario, Gunnar, et al.
  Izdano: (2014)